Can a Boron-Based pill tame obesity and blood sugar?

NCT ID NCT05741606

Completed Disease control Sponsor: Tabriz University of Medical Sciences Source: ClinicalTrials.gov ↗

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This trial is testing whether a compound called sodium pentaborate pentahydrate can help people with overweight or obesity lose weight and improve their blood sugar. Participants will receive either the compound or a placebo, and researchers will track changes in body weight, waist size, and other health measures. The study aims to see if this approach is safe and effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: sodium pentaborate pentahydrate
What this could lead to: If it works, this could point toward a new medication to help people with overweight or obesity lose weight and improve blood sugar control.
What could go wrong: This is an early-stage trial, so the safety and effectiveness are not yet proven. The results may not lead to a widely available treatment, and there could be side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVERWEIGHT AND OBESITY

Contacts and locations

Locations

Imam Reza hospital and Clinic of Salamat

Tabriz, East Azarbayejan, 5166614766, Iran

More trials for these conditions

Other studies related to the condition(s) this trial covers.